phenyl-n-tert-butylnitrone and dinoprostone

phenyl-n-tert-butylnitrone has been researched along with dinoprostone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horner, PJ; Milatovic, D; Montine, KS; Montine, TJ; Zaja-Milatovic, S	1
Boedker, M; Boetkjaer, A; Cui, JG; Lukiw, WJ; Zhao, Y	1

Other Studies

2 other study(ies) available for phenyl-n-tert-butylnitrone and dinoprostone

Article	Year
Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. Journal of neurochemistry, 2003, Volume: 87, Issue:6 Topics: Analysis of Variance; Animals; Biomarkers; Body Temperature; Cell Count; Cyclic N-Oxides; Dendrites; Dinoprostone; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Female; Free Radical Scavengers; Immunity, Innate; Immunohistochemistry; Injections, Intraventricular; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Neurological; Nerve Degeneration; Neuroglia; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Oxidation-Reduction; Peptides; Silver Staining; Telencephalon; Time Factors; Tocopherols	2003
Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells. Neuroscience letters, 2007, Oct-09, Volume: 426, Issue:1 Topics: Anti-Inflammatory Agents; Budesonide; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Cyclooxygenase 2; Dihydropyridines; Dinoprostone; Drug Synergism; Encephalitis; Gene Expression; Humans; Neurons; Oxidative Stress; Platelet Activating Factor; Signal Transduction; Stress, Physiological; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation	2007

Article

Year

Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum.

Journal of neurochemistry, 2003, Volume: 87, Issue:6

Topics: Analysis of Variance; Animals; Biomarkers; Body Temperature; Cell Count; Cyclic N-Oxides; Dendrites; Dinoprostone; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Female; Free Radical Scavengers; Immunity, Innate; Immunohistochemistry; Injections, Intraventricular; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Neurological; Nerve Degeneration; Neuroglia; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Oxidation-Reduction; Peptides; Silver Staining; Telencephalon; Time Factors; Tocopherols

2003

Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.

Neuroscience letters, 2007, Oct-09, Volume: 426, Issue:1

Topics: Anti-Inflammatory Agents; Budesonide; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Cyclooxygenase 2; Dihydropyridines; Dinoprostone; Drug Synergism; Encephalitis; Gene Expression; Humans; Neurons; Oxidative Stress; Platelet Activating Factor; Signal Transduction; Stress, Physiological; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation

2007